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1684-1182/Copyright ª 2015, TaiwanAbstract Background/purpose: Efflux pumps are one of the major mechanisms of antimicro-
bial resistance in Acinetobacter baumannii. This study aimed to understand the distribution of
different types of pump genes in clinical isolates of multidrug-resistant A. baumannii (MDRAB)
and to reveal the relationship between their presence and expression with antimicrobial resis-
tance.
Methods: MDRAB isolates were collected from five hospitals in Taiwan. Different categories of
pump genes, including adeB, adeJ, macB, abeM, abeS, emrA-like, emrB-like, and craA, were
chosen, and their presence in the collected isolates was determined. Three induced resistant
strains of A. baumannii ATCC 17978 to tigecycline, imipenem, and amikacin were also
included. The expressions of the selected pump genes were determined using quantitative
reverse transcription-polymerase chain reaction.
Results: Twenty-one MDRAB clinical isolates were obtained from five hospitals. All of the stud-
ied pump genes were present in the collected MDRAB isolates except one isolate that lacked
the emrA-like gene. The gene expression of these efflux pumps was variable among the strains.
The upregulation of the adeB, adeJ, and macB genes was responsible for tigecycline resis-
tance, and the increased abeS expression was strongly related to amikacin resistance. Of allMolecular and Cellular Biology, National Tsing Hua University, Number 101, Section 2, Kuang-Fu Road,
u.tw (C.-Y. Lan).
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http://dx.doi.org/10.1016/j.jmii.201the antibiotics studied, tigecycline was the strongest inducer of gene expression for many
efflux pumps in A. baumannii.
Conclusion: Efflux pump genes are universally present in the collected clinical MDRAB isolates.
The upregulation of the adeB, adeJ, macB and abeS genes is more related with antibiotic resis-
tance.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Acinetobacter baumannii has evolved from being a
commensal bacteria in health care facilities to constitute
one of the most important microorganisms responsible for
nosocomial infections and hospital outbreaks in recent
decades.1 The reasons for the success of A. baumannii may
be related to the potential for this organism to achieve
dynamic reorganization and rapid evolution of its genome,
including the acquisition and expression of exogenous
antibiotic resistance genes under environmental selective
pressure.2 A global surveillance study of A. baumannii
noted significant increases in antimicrobial resistance
worldwide from 2004 to 2009.3 The isolates collected from
Asia and the Pacific Rim in a previous study demonstrated
increases in resistance for all antimicrobials, ranging from a
19.1% increase in ceftazidime resistance to a 38.9% increase
in levofloxacin resistance. The imipenem (IPM) resistance
rate of A. baumannii from another worldwide collection
between 2005 and 2009 reached resistance rates > 50%.4
The major mechanisms known to confer resistance to
different class of antibiotics in A. baumannii include b-
lactamases, aminoglycoside-modifying enzymes, perme-
ability defects, multidrug efflux pumps, and alteration of
target sites.5,6 Among these mechanisms, the role of bac-
terial efflux pumps in multidrug resistance has been
emphasized.7,8 Antimicrobials are excreted out of the cell,
which leads to a reduction in drug accumulation and an
increase in minimum inhibitory concentrations (MICs).9
Each efflux pump consists of three components: the inner
membrane transporter, the outer membrane channel, and
the periplasmic lipoprotein.10 Multidrug efflux pumps are
generally chromosome-encoded, and their expressions
often result from mutations in regulatory genes. However,
drug-specific efflux pumps are encoded by mobile genetic
elements whose acquisition is sufficient for resistance.11
Four categories of efflux pumps, including the resis-
tanceenodulationedivision (RND) family, major facilitator
superfamily (MFS), multidrug and toxic compound extrusion
(MATE) family, and small multidrug resistance (SMR) family
of transporters, have been linked to A. baumannii antimi-
crobial resistance.9 Of these different pumps, the RND and
MFS families of transporters have been the most studied.
AdeABC, a RND-type efflux pump, is not only associated
with aminoglycoside resistance,12 but is also involved in the
level of susceptibility to many antibiotics, including tige-
cycline (TGC).13 Overexpression of other RND-type efflux
pumps, including AdeFGH and AdeIJK, contributes to
multidrug resistance in A. baumannii.14,15 A number of MFSin M-F, et al., Distribution of diff
orrelation with antimicrobial resi
5.04.004efflux pumps, including TetA,16 CmlA,8 CraA,17 and AmvA,18
mediate resistance to different types of antibiotics. A
mutant of AbeS, an SMR efflux pump, exhibits erythromycin
and chloramphenicol resistance in A. baumannii,19 whereas
a MATE family pump, AbeM, was reported to confer resis-
tance to fluoroquinolones and IPM.20
Fournier et al21 have described 46 open reading frames
(ORFs) that are putatively associated with resistance to
antimicrobials outside an 86-kb gene resistance island using
a comparative genomic approach. Of these 46 ORFs, 32 ORFs
were associated with the RND family, seven with the MFS,
two with the MATE family, and one with the SMR family.
Although these previous studies have revealed the contri-
bution of different categories of efflux pumps to antimi-
crobial resistance in A. baumannii, the role of some other
efflux pumps, such as MacAB-tolC and EmrAB, which have
been well described in other species of bacteria,22,23 have
yet to be explored. Because the choice of antimicrobial
treatment for multidrug resistant A. baumannii (MDRAB) is
severely limited, there are only few effective options
available, including polymyxins and TCGs.5 Therefore, this
study aimed to understand the distribution of different
types of pump genes in clinical isolates of A. baumannii and
to reveal the relationship between their presence and
expression with antimicrobial resistance to provide a basis
for developing new targets for future therapies.
Methods
Specimen collection and strain identification
MDRAB isolates were collected from five hospitals in Taiwan
with five isolates from the Hsin-Chu branch of National
Taiwan University Hospital (NTUH), four from the Chut-Tung
branch of NTUH, seven from the Hsin-Chu branch of Taipei
Veterans General Hospital, four from Catholic Mercy Medi-
cal Foundation, and one from Hualien Tzu Chi Hospital.
Each isolate was sampled from a different patient and
classified as genus Acinetobacter using the Vitek system
(Biomerieux Vitek, Inc., Hazelwood, MO, USA). A. bau-
mannii was further identified by one-tube multiplex poly-
merase chain reaction (PCR) based on the method of Chen
et al.24
Induction of resistance for amikacin, IPM, or TGC
The induced TGC-resistant A. baumannii strain was from
our previous study,25 whereas the induced amikacin (AMK)-erent efflux pump genes in clinical isolates of multidrug-resistant
stance, Journal of Microbiology, Immunology and Infection (2015),
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+ MODELresistant and IPM-resistant A. baumannii strains were from
a study by Kuo et al.26 Serial passaging was performed as
previously described by Li at al27 with several
modifications.
Antimicrobial susceptibility tests
Susceptibilities to antimicrobial agents were determined
using the microdilution method in accordance with the
guidelines of the Clinical and Laboratory Standards Insti-
tute.28 The tested agents included ampicillin/sulbactam
(SAM), piperacillin/tazobactam, cefazolin, cefmetazole,
cefotaxime, ceftazidime, cefepime (FEP), IPM, meropenem
(MEM), AMK, gentamicin, ciprofloxacin, levofloxacin,
trimethoprim/sulfamethoxazole, and TGC.
Detection of different efflux pump genes in clinical
isolates of MDRAB
Different categories of pump genes were chosen to deter-
mine their presence in the collected clinical isolates of
MDRAB to understand their distribution, including RND
pump genes adeJ and adeB, MFS pump genes craA and
emrB-like (A1S_1772), membrane fusion protein gene
emrA-like (A1S_1800), MATE group abeM, SMR group abeS,
and macrolide ABC transporter gene macB (A1S_0536). The
primers used for detection of the selected genes are listed
in Table 1.
DNA manipulation
Plasmid DNA was prepared with the FavorPrep Plasmid DNA
Extraction Mini Kit (Favorgen, Ping-Tung, Taiwan). A. bau-
mannii genomic DNA was extracted as described previ-
ously.29 Briefly, PCR amplification was performed in a
Thermo Hybaid PXE 0.2 HBPX02 Thermal Cycler (Thermo
Scientific, Redwood, CA, USA), using ProTaq DNATable 1 Oligonucleotides used in this study.
Primer name Sequence (50 to 30)
qadeB_F ACAAGACCGCGCTAACTTAGGT
qadeB_R TGCCATTGCCATAAGTTCATCT
qadeJ_F AGCTGGTGCTATGGGCGTTA
qadeJ_R GCCACCCCATGCAATACG
qmacB_F CGGAATGGGTTCGGATGAC
qmacB_R CGGCTCATGACCGTGGTATAA
qemrB_F GCGGGATGATTCCGACTTC
qemrB_R TGAGCGTTTTGGTTCTGGAAA
qemrA_F AACAGAGGCCCAGCTTAGAAAA
qemrA_R AGCGTGCGGTATTATCTTTAGTGA
qabeS_F TGTGGGTTATGCAGTTGCTTTT
qabeS_R GGCATAGGCAATCCCGATT
qabeM_F TGGGTATGCCCGCTGTAAC
qabeM_R ATGGCCTAATGCTTCGGAATAG
qcraA_F CCTGATTCAGCCAGCCATGT
qcraA_R GAAGACGGCGCCCAAGT
q16s rRNA_F AGCATTTCGGATGGGAACTTTA
q16s rRNA_R GTCGTCCCCGCCTTCCT
Please cite this article in press as: Lin M-F, et al., Distribution of diff
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Kit (Kapa Biosystems, Boston, MA, USA). DNA fragments
were extracted from agarose gels and purified using the
GeneKlean Gel Recovery & PCR CleanUp Kit (MDBio, Inc.,
Taipei, Taiwan). Nucleotide sequences of the PCR products
were verified using an ABI 3730XL DNA Analyzer (Applied
Biosystems, South San Francisco, CA, USA).RNA isolation, reverse transcription-PCR, and
quantitative reverse transcription-PCR
RNA isolation, reverse transcription (RT)-PCR and quanti-
tative RT (qRT)-PCR methods were performed as described
in our previous study.25 The cDNAs were used in PCR re-
actions with different primers for qRT-PCR (Table 1), which
was carried out with a StepOne Real-Time PCR System (Life
Technologies, Grand Island, NY, USA). Briefly, each 20-mL
reaction mixture contained 25 ng cDNA, 10 mL Power SYBR
green PCR master mix (Life Technologies), and 300nM each
forward and reverse primer. The reactions were performed
with one cycle at 95C for 10 minutes followed by 40 cycles
of 95C for 15 seconds and 60C for 1 minute. The 16S rRNA
transcript was used as an endogenous control for qRT-PCR.
The data were analyzed using the StepOne version 2.1
software (Life Technologies).Statistical analysis
The susceptibility difference was analyzed using Student t
test. The differences between two groups of isolates were
considered significant at p < 0.05. Data entry and analyses
were performed using SPSS version 15.0 (SPSS Inc., Chicago,
IL, USA).Results
Antimicrobial susceptibility of MDRAB isolates and
induced resistant strains
All of the 21 A. baumannii clinical isolates obtained from
the five hospitals are multidrug-resistant and showed 100%
nonsusceptibility to many of the tested antimicrobial
agents, except SAM, FEP, IPM, MEM, AMK, trimethoprim/
sulfamethoxazole, and TGC (Table 2). Two isolates, VGH2
and VGH7, showed pan-drug resistance, whereas the CT11
and CT13 isolates had more antimicrobial susceptibility
than the others. Both AMK and TGC were the most effective
antimicrobials against the collected isolates (71.4% sus-
ceptible, 15/21). Of the collected isolates, 19.0% (4/21)
were susceptible to trimethoprim/sulfamethoxazole, and
only 9.5% (2/21) were susceptible to SAM, FEP, IPM, or MEM.
The antibiograms of VGH1 and VGH2 were similar to those
of the amikacin-induced strain (ABamk) and imipenem-
induced strain (ABipm), respectively. VGH7 had the high-
est TGC MIC ( 8 mg/mL). Therefore, the VGH1, VGH2,
VGH7, HC4, CT11, and CT13 strains along with the wild
type, induced and ABhl1 strains were chosen for analysis of
pump gene expression by qRT-PCR.erent efflux pump genes in clinical isolates of multidrug-resistant
stance, Journal of Microbiology, Immunology and Infection (2015),
Table 2 Antimicrobial susceptibility of the collected MDRAB isolates and induced-resistant strains.
Strains SAM TZP CFZ CMZ CTX CAZ FEP IPM MEM AMK GEN CIP LVX SXT TGC
ABwt S ( 2) S ( 4) R ( 64) R (32) S (8) S (2) S ( 1) S ( 0.25) S ( 0.25) S ( 2) S ( 1) S ( 0.25) S ( 0.12) S (40) S ( 2)
ABtc S ( 2) S ( 4) R ( 64) R ( 64) S (8) S (4) S (4) S ( 0.25) S ( 0.25) S ( 2) S (4) I (2) S (1) R (160) R ( 8)
ABipm S (8) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R ( 64) I (8) R ( 16) R ( 64) R ( 16) R ( 4) R ( 8) R ( 320) I (4)
ABamk R ( 32) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R ( 64) R ( 16) R ( 16) S (4) R ( 16) R ( 4) R ( 8) R ( 320) S ( 2)
ABhl1 I (16) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R (32) R ( 16) R ( 16) S (4) R ( 16) R ( 4) R ( 8) R ( 320) R ( 8)
VGH1 R ( 32) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R ( 64) R ( 16) R ( 16) S (4) R ( 16) R ( 4) R ( 8) R ( 320) S ( 2)
VGH2 R ( 32) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R (32) I (8) R ( 16) R ( 64) R ( 16) R ( 4) R ( 8) R ( 320) R (8)
VGH3 I (16) R ( 128 R ( 64) R ( 64) R ( 64) R ( 64) R (32) I (8) R ( 16) S ( 2) R ( 16) R ( 4) R ( 8) R ( 320) R (8)
VGH4 R ( 32) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R ( 64) R ( 16) R ( 16) S ( 2) R ( 16) R ( 4) R ( 8) R ( 320) R (8)
VGH5 R ( 32) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R ( 64) R ( 16) R ( 16) S ( 2) R ( 16) R ( 4) R ( 8) R ( 320) S ( 2)
VGH6 I (16) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R ( 64) R ( 16) R ( 16) S (8) R ( 16) R ( 4) R ( 8) S ( 20) R ( 8)
VGH7 R ( 32) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R (32) R ( 16) R ( 16) R ( 64) R ( 16) R ( 4) R ( 8) R ( 320) R ( 8)
HC1 I (16) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R ( 64) R ( 16) R ( 16) S (4) R ( 16) R ( 4) I (4) S ( 20) S ( 2)
HC2 R ( 32) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R ( 64) R ( 16) R ( 16) S (4) R ( 16) R ( 4) R ( 8) R (160) S ( 2)
HC3 R ( 32) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R (32) R ( 16) R ( 16) R ( 64) R ( 16) R ( 4) R ( 8) R ( 320) S ( 2)
HC4 R ( 32) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R ( 64) R ( 16) R ( 16) R ( 64) R ( 16) R ( 4) R ( 8) R ( 320) S ( 2)
HC5 R ( 32) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R (32) R ( 16) R ( 16) S (4) R ( 16) R ( 4) R ( 8) R (160) S ( 2)
CT11 S (4) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) I (16) S (1) S (0.5) S (4) R ( 16) R ( 4) R ( 8) R (160) S ( 2)
CT12 R ( 32) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R ( 64) R ( 16) R ( 16) R (8) R ( 16) R ( 4) R ( 8) R (160) S ( 2)
CT13 I (16) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R (32) S (1) S (1) S ( 2) S ( 1) R ( 4) R ( 8) R ( 320) S ( 2)
CT14 R ( 32) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R ( 64) R ( 16) R ( 16) S (8) R ( 16) R ( 4) R ( 8) R (160) S ( 2)
CM1 R ( 32) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R ( 64) R ( 16) R ( 16) S ( 2) S ( 1) R ( 4) R ( 8) S ( 20) S ( 2)
CM2 S (4) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) I (16) R ( 16) R ( 16) S ( 2) R ( 16) R ( 4) R ( 8) R ( 320) S ( 2)
CM3 I (16) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R (32) R ( 16) R ( 16) S ( 2) R ( 16) R ( 4) R ( 8) R ( 320) S ( 2)
CM4 I (16) R ( 128) R ( 64) R ( 64) R ( 64) R ( 64) R ( 64) R ( 16) R ( 16) S ( 2) R ( 16) R ( 4) R ( 8) S ( 20) S ( 2)
ABamk Z amikacin-induced ABwt; ABhl1 Z an Acinetobacter baumannii strain from Hualien Tzu Chi Hospital; ABipm Z imipenem-induced ABwt; ABtc Z induced tigecycline-resistant
ABwt; ABwtZ A. baumannii ATCC 17978; AMK Z amikacin; CAZZ ceftazidime; CFZZ cefazolin; CIPZ ciprofloxacin; CMZ Catholic Mercy Hospital; CMZZ cefmetazole; CTZ Chut-
Tung branch of National Taiwan University Hospital; CTX Z cefotaxime; FEP Z cefepime; HC Z Hsin-Chu branch of National Taiwan University Hospital; I Z intermediate;
IPM Z imipenem; GEN Z gentamicin; LVX Z levofloxacin; MEM Z meropenem; R Z resistant; S Z susceptible; SAM Z ampicillin/sulbactam; SXT Z trimethoprim/sulfamethoxazole;
TGC Z tigecycline; TZP Z piperacillin/tazobactam; VGH Z Hsin-chu branch of Taipei Veterans General Hospital.
4
M
.-F.
Lin
e
t
a
l.
+
M
O
D
E
L
P
le
a
se
cite
th
is
a
rticle
in
p
re
ss
a
s:
Lin
M
-F,
e
t
a
l.,
D
istrib
u
tio
n
o
f
d
iffe
re
n
t
e
ffl
u
x
p
u
m
p
ge
n
e
s
in
clin
ica
l
iso
la
te
s
o
f
m
u
ltid
ru
g-re
sista
n
t
A
cin
e
to
b
a
cte
r
b
a
u
m
a
n
n
ii
a
n
d
th
e
ir
co
rre
la
tio
n
w
ith
a
n
tim
icro
b
ial
re
sista
n
ce
,
Jo
u
rn
a
l
o
f
M
icro
b
io
lo
gy,
Im
m
u
n
o
lo
gy
a
n
d
In
fe
ctio
n
(2015),
h
ttp
://d
x.d
o
i.o
rg/10.1016/j.jm
ii.2015.04.004
T
a
b
le
3
R
e
la
ti
ve
e
xp
re
ss
io
n
a
o
f
e
ffl
u
x
p
u
m
p
ge
n
e
s
in
so
m
e
co
ll
e
ct
e
d
M
D
R
A
B
is
o
la
te
s
a
n
d
in
d
u
ce
d
re
si
st
a
n
t
st
ra
in
s.
St
ra
in
s
a
d
e
B
a
d
e
J
m
a
cB
a
b
e
S
e
m
rA
b
e
m
rB
c
a
b
e
M
cr
a
A
A
B
w
t
1.
05

0.
35
1.
00

0.
11
1.
01

0.
20
1.
00

0.
11
1.
01

0.
14
1.
00

0.
10
1.
02

0.
22
1.
02

0.
28
A
B
tc
32
9.
09

86
.0
0*
9.
29

1.
91
*
12
.2
6

0.
67
**
*
0.
65

0.
06
*
1.
96

0.
08
**
4.
30

0.
44
**
2.
01

0.
28
**
2.
25

0.
13
**
A
B
ip
m
58
.2
2

22
.2
2*
1.
74

0.
06
**
2.
14

0.
36
*
16
.5
3

2.
69
**
0.
60

0.
07
*
0.
39

0.
07
**
3.
52

0.
71
*
1.
62

0.
25
A
B
a
m
k
22
.9
2

17
.6
5
1.
21

0.
20
2.
39

0.
45
*
16
.4
3

1.
95
**
0.
33

0.
03
*
0.
97

0.
07
1.
70

0.
11
*
1.
40

0.
25
A
B
h
l1
98
.9
4

25
.4
7*
4.
73

0.
88
*
2.
91

0.
72
*
6.
52

1.
18
*
0.
68

0.
18
0.
45

0.
16
**
1.
26

0.
15
0.
41

0.
11
*
V
G
H
1
10
.1
8

8.
84
1.
25

0.
16
1.
18

0.
05
5.
23

1.
26
*
0.
43

0.
29
0.
48

0.
08
**
2.
15

0.
27
**
0.
78

0.
10
V
G
H
2
36
.0
7

11
.6
2*
1.
03

0.
11
1.
93

0.
45
15
.7
6

3.
63
*
0.
30

0.
11
**
0.
19

0.
04
**
2.
96

0.
30
**
1.
41

0.
06
V
G
H
7
47
.5
0

7.
49
*
3.
01

0.
75
*
6.
24

1.
19
*
17
.2
4

3.
26
*
0.
34

0.
13
**
0.
21

0.
04
**
4.
46

0.
67
**
0.
99

0.
12
H
C
4
1.
86

1.
03
0.
55

0.
20
*
1.
54

0.
29
25
.3
4

2.
13
**
0.
27

0.
15
**
0.
26

0.
13
**
1.
73

0.
29
*
0.
27

0.
08
*
C
T
11
30
.1
0

8.
71
*
0.
36

0.
19
*
1.
73

0.
13
*
8.
38

2.
49
*
0.
52

0.
12
*
0.
93

0.
20
4.
07

0.
66
**
1.
18

0.
12
C
T
13
4.
91

1.
63
*
0.
56

0.
27
0.
42

0.
20
*
12
.4
2

0.
93
**
0.
00

0.
00
**
0.
31

0.
19
*
5.
42

0.
92
*
0.
36

0.
29
*
a
T
h
e
n
u
m
b
e
rs
in
th
e
ce
ll
s
re
p
re
se
n
t
fo
ld
ch
a
n
ge
s
co
m
p
a
re
d
to
th
o
se
o
f
A
B
w
t.
b
e
m
rA
re
p
re
se
n
ts
A
1S
_1
80
0.
c
e
m
rB
re
p
re
se
n
ts
A
1S
-1
77
2.
A
B
a
m
k
Z
a
m
ik
a
ci
n
-i
n
d
u
ce
d
A
B
w
t;
A
B
ip
m
Z
im
ip
e
n
e
m
-i
n
d
u
ce
d
A
B
w
t;
A
B
h
l1
Z
a
n
A
ci
n
e
to
b
a
ct
e
r
b
a
u
m
a
n
n
ii
st
ra
in
fr
o
m
H
u
al
ie
n
T
zu
C
h
i
H
o
sp
it
a
l;
A
B
tc
Z
ti
ge
cy
cl
in
e
-i
n
d
u
ce
d
A
B
w
t;
A
B
w
t
Z
A
.
b
a
u
m
a
n
n
ii
A
T
C
C
17
97
8;
C
T
Z
C
h
u
t-
Tu
n
g
b
ra
n
ch
o
f
N
a
ti
o
n
a
l
T
a
iw
a
n
U
n
iv
e
rs
it
y
H
o
sp
it
a
l;
H
C
Z
H
si
n
-C
h
u
b
ra
n
ch
o
f
N
a
ti
o
n
al
T
a
iw
a
n
U
n
iv
e
rs
it
y
H
o
sp
it
a
l;
V
G
H
Z
H
si
n
-c
h
u
b
ra
n
ch
o
f
T
a
ip
e
i
V
e
te
ra
n
s
G
e
n
e
ra
l
H
o
sp
it
a
l.
*p

0.
05
;
**
p

0.
01
;
**
*p

0.
00
1.
Efflux pumps in A. baumannii 5
+ MODELDistribution of different pump genes in the clinical
isolates of MDRAB
Based on the National Center for Biotechnology Informa-
tion database (http://www.ncbi.nlm.nih.gov/gene/?
termZA1S_0538), A1S_0535 (tolC ), A1S_0536 (macB),
A1S_0537, and A1S_0538 (macA) are counterparts of the
macAB_tolC gene in A. baumannii ATCC 17978. The emrB-
like gene A1S_1772 and gene A1S_1773 were shown to
function as an operon by RT-PCR along with A1S_1799 and
emrA-like gene A1S_1800 (data not shown). RND pumps
adeJ and adeB, MFS pump craA and emrB-like (A1S_1772)
genes, MATE group abeM, SMR group abeS, and macrolide
ABC transporter gene macB (A1S_0536) were all present in
the 24 clinical isolates of MDRAB, the wild-type strain, and
their induced resistant strains. Membrane fusion protein
gene emrA-like (A1S_1800) was also present in all of the
studied isolates except one from the Chu-Tung branch of
the NTUH (CT3).
Relative expression of efflux pump genes in
MDRAB
In all of the studied MDRAB strains, including three
antibiotic-induced strains and seven clinical isolates,
adeB, abeS, and abeM gene expressions all increased
compared with that of A. baumannii ATCC 17978, although
the increase in adeB gene expression in ABtc, VGH1, and
HC4 and abeM gene expression in ABhl1 were not statis-
tically significant (Table 3). By contrast, the relative
expression of emrA-like gene A1S_1800 and emrB-like
gene A1S_1772 decreased in all of the studied MDRAB
strains except ABtc, which still showed increased expres-
sion of these two genes. However, the relative gene
expression of adeJ, macB, and craA varied among the
studied MDRAB strains. ABtc, ABipm, ABhl1, and VGH7 had
increased adeJ gene expression, whereas HC4 and CT11
showed decreased relative gene expression of adeJ. Six
strainsdABtc, ABipm, ABamk, ABhl1, VGH7, and
CT11dhad increased expression of macB, but CT13
showed decreased expression. The decreased relative
expression of craA could be observed in ABhl1, HC4, and
CT13, and ABtc was the only strain with significantly
increased craA gene expression.
Relationship of the expression of efflux pump
genes and antimicrobial resistance
Because the collected MDRAB were resistant to most of
the tested antibiotics, especially b-lactam antibiotics and
fluoroquinolones, only the antimicrobial susceptibility of
AMK and TGC were chosen for further analysis. To reveal
the relationship between efflux pump genes and their
expression, each antibiotic category was divided into two
groups with MIC values of  64 mg/mL and  8 mg/mL for
AMK (Figure 1) and TGC (Figure 2), respectively. The
strains with TGC MIC  8 mg/mL had more gene expression
of adeB (p Z 0.059), adeJ (p Z 0.023), and macB
(p Z 0.033) than the susceptible strains, whereas statis-
tically significantly increased expression of the abeS gene
was observed in the AMK-resistant group (p Z 0.008).Please cite this article in press as: Lin M-F, et al., Distribution of different efflux pump genes in clinical isolates of multidrug-resistant
Acinetobacter baumannii and their correlation with antimicrobial resistance, Journal of Microbiology, Immunology and Infection (2015),
http://dx.doi.org/10.1016/j.jmii.2015.04.004
Figure 1. Relationship between pump gene expression and amikacin resistance. The clinical isolates were divided into two
groups by minimum inhibitory concentration (MIC) values with a cutoff point of  64 mg/mL for amikacin. The strains with amikacin
MICs  64 mg/mL had more gene expression of abeS than the more susceptible strains (p Z 0.008).
6 M.-F. Lin et al.
+ MODELDiscussion
The role of efflux pumps in the antimicrobial resistance of
A. baumannii is well reviewed in several previous re-
ports.8,9 The linear relationship between the log-Figure 2. Relationship between pump gene expression and tige
groups by minimum inhibitory concentration (MIC) values with a
tigecycline MICs  8 mg/mL had more gene expression of adeB (pZ
susceptible strains.
Please cite this article in press as: Lin M-F, et al., Distribution of diff
Acinetobacter baumannii and their correlation with antimicrobial resi
http://dx.doi.org/10.1016/j.jmii.2015.04.004transformed expression values of the AdeABC efflux pump
genes and the log-transformed TGC MIC values provides
solid evidence of the contribution of some efflux pumps to
the resistance to certain antimicrobials.30 The importance
of efflux pumps in multidrug resistance in A. baumannii iscycline resistance. The clinical isolates were divided into two
cutoff point of  8 mg/mL for tigecycline. The strains with
0.059), adeJ (pZ 0.023), and macB (pZ 0.033) than the more
erent efflux pump genes in clinical isolates of multidrug-resistant
stance, Journal of Microbiology, Immunology and Infection (2015),
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+ MODELfurther supported by the fact that the presence of efflux
pump inhibitors, such as 1-(1-naphthylmethyl)-pipera-
zine,31 phenyl-arginine-b-naphthylamide,31 or carbonyl cy-
anide 3-chlorophenylhydrazone,32 can reverse the
resistance pattern. However, the previous studies of the
relationship between individual efflux pumps and antimi-
crobial resistance were often undertaken in reference
strains or a single clinical isolate. Few studies have dealt
with differences in the phenotype of antimicrobial resis-
tance and efflux pump gene expression among MDRAB
clinical isolates from the different hospitals or sources. Our
study showed the complexity of the relationship between
pump gene expression and antimicrobial resistance in
MDRAB. It is known that the mechanisms contributing to
antimicrobial resistance of MDRAB, at least including b-
lactamases, multidrug efflux pumps, aminoglycoside-
modifying enzymes, and alteration of permeability, are
complicated.5,6 By analyzing the qRT-PCR results of this
study, the efflux pumps only play a partial role on multidrug
resistance of MDRAB. The resistance to one type of antibi-
otics often involves several relevant efflux pumps, if any,
and one type of efflux pump system can contribute resis-
tance to different classes of antibiotics simultaneously in A.
baumannii. Because the efflux pumpdfor example, AdeAB
in A. baumannii ATCC 17978dcan recruit another outer
membrane protein to form a functional tripartite complex,8
the activities of the pump systems were evaluated mainly
through measuring the transporter gene (e.g., adeJ, macB,
adeB) expression, not porin gene (e.g., adeK, tolC, adeC )
expression, by qRT-PCR in this study.
Currently, little is known about the epidemiology of
various efflux pumps in A. baumannii. It was estimated that
53e97% of A. baumannii clinical strains harbor the adeABC
operon,8 but the presence of other pump genes have not
been explored yet. The high prevalence rate of the
different efflux pump genes in the clinical isolates of
MDRAB in the present study suggested that MDRAB may be
equipped with more machinery to adapt to its environment
and survive. This notion is supported by the concept pro-
posed by Piddock,33 who thought that multidrug-resistance
efflux pumps have roles in bacterial pathogenicity. How-
ever, the number of the clinical isolates in this study is
limited, which may not be representative of the clinical
isolates from the general population. Therefore, a large-
scale study is necessary to verify our hypothesis in the
future.
The emergence of MDRAB is worldwide. The Taiwan
Surveillance of Antimicrobial Resistance program showed
from 2002 to 2010 that the prevalence of the extensively
drug-resistant A. baumannii complex (XDRABC) increased
from 1.3% in 2002 to 41.0% in 2012.34 One of the risk fac-
tors, acquiring XDRABC, is prior broad-spectrum antibiotic
use. Because A. baumannii acquires resistance traits easily
in the hospital environment with an abundance of antibi-
otics, we mimicked the same process in the laboratory
through induction of the wild-type strains to enhance
development of their resistance to TGC, IPM, and AMK. IPM
and AMK are strong inducers of an antimicrobial resistance
phenotype in A. baumannii with moderately upregulated
expression of most pump genes, whereas TGC exposure
induced TGC and trimethoprim/sulfamethoxazole resis-
tance with markedly increased gene expression of adeB,Please cite this article in press as: Lin M-F, et al., Distribution of diff
Acinetobacter baumannii and their correlation with antimicrobial resi
http://dx.doi.org/10.1016/j.jmii.2015.04.004adeJ, macB, and emrB. It is obvious that the emergence of
antimicrobial resistance after induction by these three
antibiotics is not all through upregulation of the efflux
pump systems. However, by analyzing the antimicrobial
susceptibility test and pump gene expression of ABtc, we
can speculate that TGC is a strong inducer of gene
expression for many drug transporters, but is not a potent
inducer of multidrug resistance like IPM26 in A. baumannii.
The main resistance mechanism for b-lactam antibiotics
and fluoroquinolones are b-lactamases and DNA gyrase,
respectively.1 No definite relationship between the studied
efflux pump gene expression and resistance to these two
classes of antibiotics could be observed in the present
study. According to the results in Table 3 and Figure 1, we
assume that AdeABC, AdeIJK, and MacAB-TolC are impor-
tant efflux pump systems that contribute to the antimi-
crobial resistance of certain antibiotics, especially TGC.
Previous studies have shown that abeS and abeM can confer
resistance to some antibiotics.19,20 Our study also showed
that both genes had upregulated gene expression in most of
the tested strains. In addition, the AMK-resistant group had
a statistically significant expression increase of the abeS
gene. Although EmrAB pumps have been shown to be
associated with resistance to certain antibiotics in Escher-
ichia coli, and CraA was displaying strong substrate affinity
toward chloramphenicol, it seems that they are not
important pump systems that contribute antimicrobial
resistance to MDRAB.
In conclusion, we found that the studied efflux pump
genes are universally present in the collected clinical
MDRAB strains, which had varied pump gene expression.
The upregulation of adeB, adeJ, and macB genes are
responsible for TGC resistance, and the increased abeS
expression is strongly related with AMK resistance. Of all
the antibiotics studied, TGC is the strongest inducer of gene
expression for many efflux pumps in A. baumannii. All of
these findings pave a path for the development of efflux
pump inhibitors as adjuvant therapies in combating MDRAB.Conflicts of interest
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